Wei Cang

651 total citations · 1 hit paper
19 papers, 470 citations indexed

About

Wei Cang is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Wei Cang has authored 19 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Wei Cang's work include Endometrial and Cervical Cancer Treatments (3 papers), Cervical Cancer and HPV Research (3 papers) and Congenital Diaphragmatic Hernia Studies (3 papers). Wei Cang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Cervical Cancer and HPV Research (3 papers) and Congenital Diaphragmatic Hernia Studies (3 papers). Wei Cang collaborates with scholars based in China. Wei Cang's co-authors include Yu Gu, Lihua Chen, Pengming Sun, Yang Xiang, Lihua Qiu, Liying Gu, Anyue Wu, Yang Xiang, Wen Di and Xirun Wan and has published in prestigious journals such as The Lancet Oncology, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Wei Cang

18 papers receiving 465 citations

Hit Papers

Lactate-Lactylation Hands between Metabolic Reprogramming... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
    2022 214 citations Lihua Chen, Yu Gu et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Cang China 9 213 159 100 90 79 19 470
Victoria Cookson United Kingdom 9 225 1.1× 134 0.8× 119 1.2× 58 0.6× 116 1.5× 14 430
Jinxiao Liang China 12 192 0.9× 83 0.5× 108 1.1× 53 0.6× 63 0.8× 24 366
Xiaoping Xia China 12 177 0.8× 170 1.1× 160 1.6× 30 0.3× 41 0.5× 36 451
Shigenori Furukawa Japan 12 162 0.8× 115 0.7× 138 1.4× 59 0.7× 54 0.7× 42 449
Zhaolei Cui China 15 311 1.5× 265 1.7× 137 1.4× 69 0.8× 52 0.7× 51 539
K. Oliva Australia 8 120 0.6× 67 0.4× 164 1.6× 50 0.6× 67 0.8× 13 431
Ziba Nariman‐Saleh‐Fam Iran 17 419 2.0× 309 1.9× 59 0.6× 29 0.3× 67 0.8× 39 610
Britt Hanson United Kingdom 11 242 1.1× 68 0.4× 103 1.0× 49 0.5× 37 0.5× 19 511
Namiko Yada-Hashimoto Japan 9 244 1.1× 127 0.8× 134 1.3× 63 0.7× 65 0.8× 10 551
Zhijie Yu China 10 326 1.5× 203 1.3× 78 0.8× 16 0.2× 108 1.4× 17 644

Countries citing papers authored by Wei Cang

Since Specialization
Citations

This map shows the geographic impact of Wei Cang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cang more than expected).

Fields of papers citing papers by Wei Cang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Cang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cang. The network helps show where Wei Cang may publish in the future.

Co-authorship network of co-authors of Wei Cang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Cang. A scholar is included among the top collaborators of Wei Cang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Cang. Wei Cang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Li, Chen, et al.. (2023). The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge. Frontiers in Immunology. 14. 1195476–1195476. 16 indexed citations
3.
Xue, Wei, Wei Cang, Jun Zhao, et al.. (2023). Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia. International Journal of Gynecological Cancer. 33(8). 1222–1226. 1 indexed citations
4.
Gu, Yu, Dan Wang, Congwei Jia, et al.. (2023). Clinical characteristics and oncological outcomes of recurrent adult granulosa cell tumor of ovary: A retrospective study of seventy patients. Acta Obstetricia Et Gynecologica Scandinavica. 102(6). 782–790. 4 indexed citations
5.
6.
Chen, Lihua, Binhua Dong, Yu Gu, et al.. (2023). ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher. Biomedicines. 11(3). 868–868. 1 indexed citations
7.
8.
Cang, Wei, Chao Liang, Dan Wang, et al.. (2023). Oncological and Reproductive Outcomes after Fertility-Sparing Surgery in Patients with Advanced-Stage Serous Borderline Ovarian Tumor: A Single-Center Retrospective Study. Journal of Clinical Medicine. 12(18). 5827–5827. 2 indexed citations
9.
Wang, Dan, Wei Cang, Shan Zhu, et al.. (2022). Oncological and Reproductive Outcomes in Patients With Advanced-Stage Ovarian Immature Teratoma: Experience From a Tertiary Center. Frontiers in Oncology. 12. 822341–822341. 6 indexed citations
10.
Chen, Lihua, Binhua Dong, Yu Gu, et al.. (2022). Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration. Journal of Inflammation Research. Volume 15. 5889–5904. 6 indexed citations
11.
Chen, Lihua, et al.. (2022). Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. International Journal of Molecular Sciences. 23(19). 11943–11943. 214 indexed citations breakdown →
12.
Cang, Wei, Anyue Wu, Liying Gu, et al.. (2022). Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis. International Immunopharmacology. 113(Pt B). 109422–109422. 21 indexed citations
13.
Cang, Wei, Liying Gu, Zubei Hong, et al.. (2021). Effectiveness of photodynamic therapy with 5-aminolevulinic acid on HPV clearance in women without cervical lesions. Photodiagnosis and Photodynamic Therapy. 34. 102293–102293. 39 indexed citations
14.
Cheng, Hongyan, Liju Zong, Yujia Kong, et al.. (2021). Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. The Lancet Oncology. 22(11). 1609–1617. 60 indexed citations
15.
Cang, Wei, Qing Li, Liying Gu, et al.. (2020). Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening. Cancer Prevention Research. 14(3). 355–362. 5 indexed citations
16.
Lv, Yaping, Wei Cang, Quanfu Li, et al.. (2019). Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer. Oncogenesis. 8(12). 70–70. 35 indexed citations
17.
Wu, Anyue, Liying Gu, Wei Cang, et al.. (2019). Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation. Journal of Experimental & Clinical Cancer Research. 38(1). 176–176. 16 indexed citations
18.
Wu, Anyue, Yuan Hu, Wei Cang, et al.. (2019). Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis. Experimental Cell Research. 382(2). 111468–111468. 18 indexed citations
19.
Zhang, Xiujuan, Wei Cang, Lijuan He, & An Jian. (2018). Xanthotoxin induces apoptosis in SGC-7901 cells through death receptor pathway. Chinese Herbal Medicines. 10(4). 437–444. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Cookson Breakdown of academic impact, for papers by Jinxiao Liang Breakdown of academic impact, for papers by Xiaoping Xia Breakdown of academic impact, for papers by Shigenori Furukawa Breakdown of academic impact, for papers by Zhaolei Cui Breakdown of academic impact, for papers by K. Oliva Breakdown of academic impact, for papers by Ziba Nariman‐Saleh‐Fam Breakdown of academic impact, for papers by Britt Hanson Breakdown of academic impact, for papers by Namiko Yada-Hashimoto Breakdown of academic impact, for papers by Zhijie Yu
Rankless by CCL
2026